Tony Liu Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Tony Liu.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Tony Liu. Tony Liu is CEO, CFO in Cellular Biomedicine Group, Inc. ($CBMG) and Chief Financial Officer in Cellular Biomedicine Group, Inc. ($CBMG) and Director in Cellular Biomedicine Group, Inc. ($CBMG).
Latest Insider Trading Transactions of Tony Liu
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 12.40 | 120,000 | 1,488,000 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 12.55 | 30,000 | 376,500 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 20.00 | 40,000 | 800,000 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 35.53 | 30,000 | 1,065,900 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 15.53 | 105,800 | 1,643,074 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 20.63 | 15,000 | 309,450 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 20.63 | 15,000 | 309,450 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 5.00 | 255,000 | 1,275,000 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Option Exercise | J | 7.23 | 5,300 | 38,319 | 0 | |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Sell | D | 0.00 | 10,700 | 0 | 0 | 10.7 K to 0 (-100.00 %) |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Sell | J | 0.00 | 476,817 | 0 | 10,700 | 487.5 K to 10.7 K (-97.81 %) |
Feb 19 2021 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Grant | A | 0.00 | 240,000 | 0 | 487,517 | 247.5 K to 487.5 K (+96.96 %) |
Dec 27 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 12.00 | 29,167 | 350,004 | 139,167 | 110 K to 139.2 K (+26.52 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.85 | 2,900 | 19,865 | 129,025 | 126.1 K to 129 K (+2.30 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.84 | 1,200 | 8,208 | 124,925 | 123.7 K to 124.9 K (+0.97 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.80 | 800 | 5,440 | 124,925 | 124.1 K to 124.9 K (+0.64 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.85 | 100 | 685 | 124,125 | 124 K to 124.1 K (+0.08 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.84 | 2,100 | 14,364 | 124,125 | 122 K to 124.1 K (+1.72 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.83 | 2,000 | 13,660 | 121,925 | 119.9 K to 121.9 K (+1.67 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.78 | 100 | 678 | 119,925 | 119.8 K to 119.9 K (+0.08 %) |
Jun 07 2017 | CBMG | Cellular Biomedici ... | Liu Tony | CEO, CFO | Buy | P | 6.81 | 800 | 5,448 | 119,825 | 119 K to 119.8 K (+0.67 %) |
Apr 03 2017 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 12.40 | 120,000 | 1,488,000 | 120,000 | |
Apr 03 2017 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 12.55 | 30,000 | 376,500 | 30,000 | |
Apr 03 2017 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Payment of Exercise | F | 11.40 | 975 | 11,115 | 119,025 | 120 K to 119 K (-0.81 %) |
Apr 03 2017 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Grant | A | 0.00 | 120,000 | 0 | 120,000 | 0 to 120 K |
Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 15.53 | 8,000 | 124,240 | 396,100 | |
Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 15.53 | 97,800 | 1,518,834 | 388,100 | |
Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 20.63 | 15,000 | 309,450 | 290,300 | |
Feb 17 2015 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Option Exercise | A | 20.63 | 15,000 | 309,450 | 275,300 | |
May 30 2014 | CBMG | Cellular Biomedici ... | Liu Tony | Chief Financial Off ... | Buy | P | 5.00 | 100,000 | 500,000 | 100,000 | 0 to 100 K |
Apr 17 2013 | CBMG | Cellular Biomedici ... | Liu Tony | Director | Buy | P | 5.00 | 700 | 3,500 | 700 | 0 to 700 |
Page: 1